Holen Sie sich die Stockscreener-App
12.39
0.32%
0.04
Handel nachbörslich:
12.39
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TNDM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$12.35
Offen:
$12.4
24-Stunden-Volumen:
1.36M
Relative Volume:
0.69
Marktkapitalisierung:
$837.19M
Einnahmen:
$796.00M
Nettoeinkommen (Verlust:
$-136.49M
KGV:
-5.9282
EPS:
-2.09
Netto-Cashflow:
$-64.24M
1W Leistung:
+5.09%
1M Leistung:
-19.65%
6M Leistung:
-36.43%
1J Leistung:
-69.87%
1-Tages-Spanne:
$11.88
$12.50
1-Wochen-Bereich:
$11.83
$13.10
52-Wochen-Spanne:
$9.98
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
Firmenname
Tandem Diabetes Care Inc
Sektor
Branche
Telefon
858-366-6900
Adresse
12400 HIGH BLUFF DRIVE, San Diego, CA
Vergleichen Sie TNDM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
12.39 | 863.54M | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-06-16 | Eingeleitet | Truist | Hold |
| 2025-04-10 | Eingeleitet | Mizuho | Neutral |
| 2025-03-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-03-03 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | Eingeleitet | Bernstein | Outperform |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-10-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-22 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-08-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-05-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-04-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-05-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-04-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-11-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-08-09 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | Eingeleitet | Wells Fargo | Overweight |
| 2020-07-31 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-07-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-18 | Bestätigt | Raymond James | Outperform |
| 2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-06 | Eingeleitet | Raymond James | Outperform |
| 2020-02-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | Eingeleitet | Guggenheim | Buy |
| 2019-10-04 | Hochstufung | UBS | Neutral → Buy |
| 2019-05-17 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-13 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2019-03-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-27 | Bestätigt | Lake Street | Buy |
| 2018-11-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-09-26 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten
Is Tandem Diabetes Care Inc. a strong candidate for buy and hold2025 Technical Patterns & Smart Swing Trading Alerts - khodrobank.com
Should you wait for a breakout in Tandem Diabetes Care Inc.July 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - Newser
Is now a turning point for Tandem Diabetes Care Inc.Stop Loss & High Conviction Investment Ideas - Newser
Analyzing recovery setups for Tandem Diabetes Care Inc. investorsTrade Volume Report & Weekly Setup with ROI Potential - Newser
What Fibonacci levels say about Tandem Diabetes Care Inc. reboundJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - Newser
Combining price and volume data for Tandem Diabetes Care Inc.Risk Management & Real-Time Chart Breakout Alerts - Newser
How to escape a deep drawdown in Tandem Diabetes Care Inc.2025 Stock Rankings & Long-Term Investment Growth Plans - Newser
Backtesting results for Tandem Diabetes Care Inc. trading strategiesJuly 2025 Levels & Reliable Entry Point Alerts - Newser
Using Ichimoku Cloud for Tandem Diabetes Care Inc. technicalsJuly 2025 Big Picture & Community Consensus Trade Signals - Newser
How to read the order book for Tandem Diabetes Care Inc.July 2025 Market Mood & Stepwise Swing Trade Plans - Newser
What to expect from Tandem Diabetes Care Inc. in the next 30 daysJobs Report & Precise Swing Trade Alerts - Newser
Published on: 2025-09-03 02:48:30 - Newser
How high can Tandem Diabetes Care Inc. stock go2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Sector ETF performance correlation with Tandem Diabetes Care Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - Newser
Why Tandem Diabetes Care Inc. is moving todayInsider Selling & Free Daily Entry Point Trade Alerts - Newser
What is Tandem Diabetes Care Inc.’s valuation compared to sectorWeekly Stock Summary & Precise Entry and Exit Recommendations - khodrobank.com
Long term hold vs stop loss in Tandem Diabetes Care Inc.July 2025 Short Interest & AI Driven Stock Reports - Newser
Tick level data insight on Tandem Diabetes Care Inc. volatilityTrade Exit Summary & Technical Pattern Based Buy Signals - Newser
Published on: 2025-09-02 05:08:07 - Newser
What is the earnings history of Tandem Diabetes Care Inc.2025 Volume Leaders & Growth-Oriented Investment Plans - خودرو بانک
Is Tandem Diabetes Care Inc. stock a smart retirement pick2025 Buyback Activity & Long-Term Growth Portfolio Plans - khodrobank.com
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say - MSN
Can Tandem Diabetes Care Inc. generate free cash flowJuly 2025 Summary & Expert-Curated Trade Recommendations - خودرو بانک
Is Tandem Diabetes Care Inc. a speculative investmentMarket Volume Summary & Fast Momentum Stock Entry Tips - khodrobank.com
Investigation Underway: Tandem Diabetes Care, Inc. (TNDM)Contact Levi & Korsinsky Over Securities Law Violations - ACCESS Newswire
News impact scoring models applied to Tandem Diabetes Care Inc.July 2025 Levels & Real-Time Stock Entry Alerts - Newser
Tandem Diabetes Care Inc. stock daily chart insightsMarket Risk Analysis & Consistent Return Strategy Ideas - Newser
Applying Wyckoff theory to Tandem Diabetes Care Inc. stockTrade Analysis Report & Daily Volume Surge Signals - Newser
Published on: 2025-08-31 20:30:16 - Newser
Diabetes warning issued over insulin pump error - MSN
What makes Tandem Diabetes Care Inc. stock price move sharplyJuly 2025 Weekly Recap & Trade Opportunity Analysis - Newser
Measuring Tandem Diabetes Care Inc.’s beta against major indicesPortfolio Return Report & Free Technical Confirmation Trade Alerts - Newser
Unpacking Tandem Diabetes Care's Sharp Intraday Move - AInvest
Tandem Diabetes Care Inc. stock volume spike explained2025 Year in Review & Weekly Top Gainers Alerts - Newser
Tandem Diabetes Care (TNDM.O) Sees Sharp Intraday Move Without Clear Catalyst - AInvest
ATTENTION Tandem Diabetes Care, Inc. (TNDM) Investors: Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Tandem Diabetes Care Surges 6.1%—Technical Signals Stay Quiet, Volume Rises - AInvest
What data driven models say about Tandem Diabetes Care Inc.’s futureOil Prices & Long-Term Growth Stock Strategies - Newser
Will Tandem Diabetes Care Inc. rebound enough to break evenWeekly Loss Report & Consistent Return Strategy Ideas - Newser
How institutional ownership impacts Tandem Diabetes Care Inc. stockQuarterly Trade Summary & Daily Entry Point Alerts - Newser
How to monitor Tandem Diabetes Care Inc. with trend dashboardsWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Sector ETF performance correlation with Tandem Diabetes Care IncWeekly Volume Report & Weekly High Conviction Ideas - Newser
Price momentum metrics for Tandem Diabetes Care Inc. explainedJuly 2025 Pullbacks & Proven Capital Preservation Tips - Newser
Finanzdaten der Tandem Diabetes Care Inc-Aktie (TNDM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tandem Diabetes Care Inc-Aktie (TNDM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morrison Susan | EVP & Chief Admin. Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
39,376 |
| Sheridan John F | PRESIDENT & CEO |
Aug 15 '25 |
Option Exercise |
0.00 |
11,453 |
0 |
115,001 |
| Carpenter Rick | Chief Technology Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,335 |
0 |
22,824 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 15 '25 |
Option Exercise |
0.00 |
2,998 |
0 |
36,258 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
3,065 |
0 |
19,102 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Aug 15 '25 |
Option Exercise |
0.00 |
2,600 |
0 |
1,795 |
| Sheridan John F | PRESIDENT & CEO |
Aug 11 '25 |
Buy |
10.23 |
10,000 |
102,318 |
106,327 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 08 '25 |
Buy |
10.89 |
13,720 |
149,404 |
25,580 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Jul 15 '25 |
Option Exercise |
0.00 |
14,545 |
0 |
25,254 |
| Carpenter Rick | Chief Technology Officer |
Jun 16 '25 |
Option Exercise |
0.00 |
406 |
0 |
21,426 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):